FilingPulse

CRVO insider transaction filings

CervoMed Inc. — 40 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen CRVO transaction legs live →

FiledFormInsiderReported transactionsSource
2026-06-154BOGER JOSHUA S — Director, 10% ownerPurchase (P): 955,414 @ $3.14 · Purchase (P): 955,414 (derivative) · Purchase (P): 955,414 (derivative)EDGAR
2026-06-104ZAVRL FRANK — DirectorGrant/award (A): 8,150 (derivative) @ $0EDGAR
2026-06-104Sabbagh Marwan — DirectorGrant/award (A): 8,150 (derivative) @ $0EDGAR
2026-06-104Quigley David — DirectorGrant/award (A): 8,150 (derivative) @ $0EDGAR
2026-06-104Poulton Jeffrey V. — DirectorGrant/award (A): 8,150 (derivative) @ $0EDGAR
2026-06-104Hollingsworth Jane H — DirectorGrant/award (A): 8,150 (derivative) @ $0EDGAR
2026-06-104Gregoire Sylvie — Director, 10% ownerGrant/award (A): 8,150 (derivative) @ $0EDGAR
2026-06-104BOGER JOSHUA S — Director, 10% ownerGrant/award (A): 8,150 (derivative) @ $0EDGAR
2026-06-104ALAM JOHN J — CEO & President, Director, 10% ownerGrant/award (A): 8,150 (derivative) @ $0EDGAR
2026-02-134Winton Matthew — Chief Commercial and BusinessGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-02-134Gregoire Sylvie — Director, 10% ownerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2026-02-134ELDER WILLIAM ROBERT — CFO, GC & SecretaryGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-02-134De Rosch Mark — EVP, RA and GA and PgMGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-02-134Blackburn Kelly — EVP, Clinical DevelopmentGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-02-134ALAM JOHN J — CEO & President, Director, 10% ownerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2025-12-054Quigley David — DirectorGrant/award (A): 16,200 (derivative) @ $0EDGAR
2025-11-194Winton Matthew — Chief Commercial and BusinessPurchase (P): 3,500 @ $8.43 · Purchase (P): 1,500 @ $7.95EDGAR
2025-11-194Gregoire Sylvie — Director, 10% ownerPurchase (P): 10,793 @ $8.46 · Purchase (P): 10,807 @ $8.46EDGAR
2025-11-194ELDER WILLIAM ROBERT — CFO, GC & SecretaryPurchase (P): 1,000 @ $8.45 · Purchase (P): 2,500 @ $8.32EDGAR
2025-11-194ALAM JOHN J — CEO & President, Director, 10% ownerPurchase (P): 10,807 @ $8.46 · Purchase (P): 10,793 @ $8.46EDGAR
2025-11-174Gregoire Sylvie — Director, 10% ownerPurchase (P): 4,447 @ $7.51 · Purchase (P): 1,707 @ $7.57 · Purchase (P): 1,693 @ $7.55EDGAR
2025-11-174ALAM JOHN J — CEO & President, Director, 10% ownerPurchase (P): 4,447 @ $7.51 · Purchase (P): 1,693 @ $7.55 · Purchase (P): 1,707 @ $7.57EDGAR
2025-11-174Winton Matthew — Chief Commercial and BusinessPurchase (P): 10,000 @ $7.57EDGAR
2025-11-134Gregoire Sylvie — Director, 10% ownerPurchase (P): 5,553 @ $7.35EDGAR
2025-11-134ELDER WILLIAM ROBERT — CFO, GC & SecretaryPurchase (P): 3,500 @ $7.44EDGAR
2025-11-134ALAM JOHN J — CEO & President, Director, 10% ownerPurchase (P): 5,553 @ $7.35EDGAR
2025-10-084Winton Matthew — Chief Commercial and BusinessGrant/award (A): 75,000 (derivative) @ $0EDGAR
2025-06-254ALAM JOHN J — CEO & President, Director, 10% ownerGrant/award (A): 8,100 (derivative) @ $0EDGAR
2025-06-254ZAVRL FRANK — DirectorGrant/award (A): 8,100 (derivative) @ $0EDGAR
2025-06-254BOGER JOSHUA S — Director, 10% ownerGrant/award (A): 8,100 (derivative) @ $0EDGAR
2025-06-254Sabbagh Marwan — DirectorGrant/award (A): 8,100 (derivative) @ $0EDGAR
2025-06-254Poulton Jeffrey V. — DirectorGrant/award (A): 8,100 (derivative) @ $0EDGAR
2025-06-254Hollingsworth Jane H — DirectorGrant/award (A): 8,100 (derivative) @ $0EDGAR
2025-06-254Gregoire Sylvie — Director, 10% ownerGrant/award (A): 8,100 (derivative) @ $0EDGAR
2025-05-144ELDER WILLIAM ROBERT — CFO, GC & SecretaryPurchase (P): 4,233 @ $8.46EDGAR
2025-02-144Gregoire Sylvie — Director, 10% ownerGrant/award (A): 60,000 (derivative) @ $0EDGAR
2025-02-144ELDER WILLIAM ROBERT — CFO & GCGrant/award (A): 27,000 (derivative) @ $0EDGAR
2025-02-144Cobuzzi Robert Joseph Jr. — Chief Operating OfficerGrant/award (A): 27,000 (derivative) @ $0EDGAR
2025-02-144Blackburn Kelly — SVP, Clinical DevelopmentGrant/award (A): 27,000 (derivative) @ $0EDGAR
2025-02-144ALAM JOHN J — CEO & President, Director, 10% ownerGrant/award (A): 60,000 (derivative) @ $0EDGAR

Recent 8-K events — CervoMed Inc.

FiledFormItems reportedSource
2026-08-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-048-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-148-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-098-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-228-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-228-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-188-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-158-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-108-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-098-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CRVO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →